Logo image of SSY

SUNLINK HEALTH SYSTEMS INC (SSY) Stock Fundamental Analysis

NYSEARCA:SSY - NYSE Arca - US86737U1025 - Common Stock - Currency: USD

0.9141  +0.02 (+2.12%)

Fundamental Rating

4

Overall SSY gets a fundamental rating of 4 out of 10. We evaluated SSY against 102 industry peers in the Health Care Providers & Services industry. No worries on liquidiy or solvency for SSY as it has an excellent financial health rating, but there are worries on the profitability. SSY is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

SSY had positive earnings in the past year.
SSY had a negative operating cash flow in the past year.
In the past 5 years SSY reported 4 times negative net income.
The reported operating cash flow has been mixed in the past 5 years: SSY reported negative operating cash flow in multiple years.
SSY Yearly Net Income VS EBIT VS OCF VS FCFSSY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

The Return On Assets of SSY (5.60%) is better than 80.39% of its industry peers.
With a decent Return On Equity value of 7.10%, SSY is doing good in the industry, outperforming 63.73% of the companies in the same industry.
Industry RankSector Rank
ROA 5.6%
ROE 7.1%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SSY Yearly ROA, ROE, ROICSSY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

With a decent Profit Margin value of 3.20%, SSY is doing good in the industry, outperforming 64.71% of the companies in the same industry.
SSY's Gross Margin of 42.96% is fine compared to the rest of the industry. SSY outperforms 71.57% of its industry peers.
In the last couple of years the Gross Margin of SSY has declined.
Industry RankSector Rank
OM N/A
PM (TTM) 3.2%
GM 42.96%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.67%
SSY Yearly Profit, Operating, Gross MarginsSSY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

8

2. Health

2.1 Basic Checks

SSY does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SSY has more shares outstanding
SSY has more shares outstanding than it did 5 years ago.
There is no outstanding debt for SSY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
SSY Yearly Shares OutstandingSSY Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2023 2024 2M 4M 6M 8M
SSY Yearly Total Debt VS Total AssetsSSY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.76 indicates that SSY is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.76, SSY is in the better half of the industry, outperforming 62.75% of the companies in the same industry.
There is no outstanding debt for SSY. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.76
ROIC/WACCN/A
WACC9.01%
SSY Yearly LT Debt VS Equity VS FCFSSY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

SSY has a Current Ratio of 4.06. This indicates that SSY is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 4.06, SSY belongs to the top of the industry, outperforming 92.16% of the companies in the same industry.
A Quick Ratio of 3.62 indicates that SSY has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 3.62, SSY belongs to the top of the industry, outperforming 92.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.06
Quick Ratio 3.62
SSY Yearly Current Assets VS Current LiabilitesSSY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M

More info and screens

1

3. Growth

3.1 Past

SSY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.95%, which is quite impressive.
SSY shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -21.10%.
The Revenue has been decreasing by -6.58% on average over the past years.
EPS 1Y (TTM)116.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.81%
Revenue 1Y (TTM)-21.1%
Revenue growth 3Y-7.28%
Revenue growth 5Y-6.58%
Sales Q2Q%-6.76%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
SSY Yearly Revenue VS EstimatesSSY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

SSY is valuated cheaply with a Price/Earnings ratio of 5.71.
Compared to the rest of the industry, the Price/Earnings ratio of SSY indicates a rather cheap valuation: SSY is cheaper than 99.02% of the companies listed in the same industry.
SSY is valuated cheaply when we compare the Price/Earnings ratio to 24.21, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.71
Fwd PE N/A
SSY Price Earnings VS Forward Price EarningsSSY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SSY Per share dataSSY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

SSY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SUNLINK HEALTH SYSTEMS INC

NYSEARCA:SSY (5/9/2025, 8:23:01 PM)

0.9141

+0.02 (+2.12%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-18 2025-02-18
Earnings (Next)05-14 2025-05-14
Inst Owners14.13%
Inst Owner Change1.35%
Ins Owners23.27%
Ins Owner Change0%
Market Cap6.44M
Analysts0
Price TargetN/A
Short Float %0.05%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.71
Fwd PE N/A
P/S 0.21
P/FCF N/A
P/OCF N/A
P/B 0.46
P/tB 0.5
EV/EBITDA N/A
EPS(TTM)0.16
EY17.5%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.65
FCFYN/A
OCF(TTM)-0.5
OCFYN/A
SpS4.44
BVpS2
TBVpS1.83
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.6%
ROE 7.1%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.2%
GM 42.96%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-10.82%
GM growth 5Y-5.67%
F-Score4
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.71%
Cap/Sales 3.3%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.06
Quick Ratio 3.62
Altman-Z 2.76
F-Score4
WACC9.01%
ROIC/WACCN/A
Cap/Depr(3y)133.35%
Cap/Depr(5y)134.66%
Cap/Sales(3y)5.57%
Cap/Sales(5y)5.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.95%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%55.81%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-21.1%
Revenue growth 3Y-7.28%
Revenue growth 5Y-6.58%
Sales Q2Q%-6.76%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-2.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-78.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-451.48%
OCF growth 3YN/A
OCF growth 5YN/A